WEX Pharmaceuticals Inc. (“WEX” or the “Company”) is a private biopharmaceutical company based in Vancouver, Canada, developing a new class of non-opioid analgesics. WEX’s proprietary platform and the lead product is Halneuron®. The active pharmaceutical ingredient in Halneuron is Tetrodotoxin (“TTX”) which is a proven sodium channel blocker.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.